XIIIth International Cancer Congress in Seattle Drawing Record Numbers Or Top Scientific Program
In Brief: NCAB Lacked Courage On Some Special Actions, Amos Says; Pick Reviewers On Ability Only, Scientist Asks
Tim Lee Carter Says He Wants Government To Abide By spirit Of 1971 Cancer Act
Johnson, Katterhagen Applaud CCOP RFA But With It Had Money For More Cancer Control
New Clinical Trials Monitoring Program To Site Visit PIs Every Three Years
Last Issue Until Aug. 20
Trending Stories
- Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
- In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook
- Pazdur leaves FDA after 25-year career that shaped the agency’s oncology regulations
BIO calls for the end of “constant turmoil,” urges the administration to “right the ship” - Pediatric cancer five-year survival rate has increased dramatically, AACR says in inaugural Pediatric Cancer Progress Report
- Anthony Letai pledges to ensure stability for extramural and intramural cancer science
- Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program









